320 related articles for article (PubMed ID: 29778607)
1. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
Saumoy M; Schneider Y; Shen N; Kahaleh M; Sharaiha RZ; Shah SC
Gastroenterology; 2018 Sep; 155(3):648-660. PubMed ID: 29778607
[TBL] [Abstract][Full Text] [Related]
2. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
Shah SC; Canakis A; Peek RM; Saumoy M
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341
[TBL] [Abstract][Full Text] [Related]
3. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
Kowada A
Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
5. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
6. Gastric intestinal metaplasia in ethnic groups in the southwestern United States.
Fennerty MB; Emerson JC; Sampliner RE; McGee DL; Hixson LJ; Garewal HS
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):293-6. PubMed ID: 1303129
[TBL] [Abstract][Full Text] [Related]
7. A screening program to test and treat for Helicobacter pylori infection: Cost-utility analysis by age, sex and ethnicity.
Teng AM; Kvizhinadze G; Nair N; McLeod M; Wilson N; Blakely T
BMC Infect Dis; 2017 Feb; 17(1):156. PubMed ID: 28219322
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival.
Yeh JM; Ho W; Hur C
Gastrointest Endosc; 2010 Jul; 72(1):33-43. PubMed ID: 20430384
[TBL] [Abstract][Full Text] [Related]
9. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
10. Screening and surveillance for gastric cancer in the United States: Is it needed?
Kim GH; Liang PS; Bang SJ; Hwang JH
Gastrointest Endosc; 2016 Jul; 84(1):18-28. PubMed ID: 26940296
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
12. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
[TBL] [Abstract][Full Text] [Related]
13. State-specific prevalence of selected health behaviors, by race and ethnicity--Behavioral Risk Factor Surveillance System, 1997.
Bolen JC; Rhodes L; Powell-Griner EE; Bland SD; Holtzman D
MMWR CDC Surveill Summ; 2000 Mar; 49(2):1-60. PubMed ID: 10965781
[TBL] [Abstract][Full Text] [Related]
14. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population.
Tan MC; Jamali T; Nguyen TH; Galvan A; Sealock RJ; Khan A; Zarrin-Khameh N; Holloman A; Kampagianni O; Ticas DH; Liu Y; El-Serag HB; Thrift AP
Am J Gastroenterol; 2022 Feb; 117(2):280-287. PubMed ID: 34908535
[TBL] [Abstract][Full Text] [Related]
15. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
Wang AY; Wong MS; Humbyrd CJ
Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
[TBL] [Abstract][Full Text] [Related]
16. Cancer statistics by race and ethnicity.
Parker SL; Davis KJ; Wingo PA; Ries LA; Heath CW
CA Cancer J Clin; 1998; 48(1):31-48. PubMed ID: 9449932
[TBL] [Abstract][Full Text] [Related]
17. Racial and ethnic differences in outcomes in older patients with acute ischemic stroke.
Qian F; Fonarow GC; Smith EE; Xian Y; Pan W; Hannan EL; Shaw BA; Glance LG; Peterson ED; Eapen ZJ; Hernandez AF; Schwamm LH; Bhatt DL
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):284-92. PubMed ID: 23680966
[TBL] [Abstract][Full Text] [Related]
18. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences.
Wu X; Chen VW; Andrews PA; Ruiz B; Correa P
Cancer Causes Control; 2007 Aug; 18(6):585-93. PubMed ID: 17406989
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS
Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235
[TBL] [Abstract][Full Text] [Related]
20. High-resolution microendoscopy for esophageal cancer screening in China: A cost-effectiveness analysis.
Hur C; Choi SE; Kong CY; Wang GQ; Xu H; Polydorides AD; Xue LY; Perzan KE; Tramontano AC; Richards-Kortum RR; Anandasabapathy S
World J Gastroenterol; 2015 May; 21(18):5513-23. PubMed ID: 25987774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
